Healthcare & Life Sciences
Atalanta Therapeutics
United Stateswww.atalantatx.com/
Atalanta Therapeutics is a series a startup based in United States. 1 investor tracked.
Activeseries-b
series-b
Stage
2018
Founded
2
Investors
About Atalanta Therapeutics
Atalanta Therapeutics is a startup founded in 2018 based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Developer of targeted RNA-modulating therapeutics for genetically defined diseases, utilizing proprietary structure-switching molecules to modulate gene expression across oncology, neurology, and rare genetic disorders.
Explore Atalanta Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.